Complement Activation by Animal Venoms

References

• Dias da Silva W., Kipnis T. L. C3: A versatile and multifuncional complement protein, Ciěncia e Cultura. Journal of the Brazilian Association for the Advancement of Science 1991; 43: 48
   Google Scholar
• Kinoshita T. Biology of complement: the overture. Immunol. Today 1991; 12: 291
   PubMedGoogle Scholar
• Mueller U. R. Insect sting allergy. Clinical picture, diagnosis and treatment. Stuttgart, Gustav Fischer 1990
   Google Scholar
• França F. O.S., Benvenuti L. A., Hui W. F., Dos Santos D. R., Hsin S. H., Picchi-Martins F. R., Cardoso J. L.C., Kamiguti A. S., Theakston R. D.G., Warrell D. A. Severe and fatal mass attacks by “killer” bees (Africanized honey bees - Apis mellifera scutellata). Brazil: clinicopathological studies with measurement of serum venom concentrations and a review of the literature. 1994, (Manuscript in preparation)
   Google Scholar
• Laine R. O., Morgan B. P., Esser A. F. Comparison between complement and melittin hemolysis: anti-melittin antibodies inhibit complement lysis. Biochemistry 1988; 27: 5308
   PubMed Web of Science ®Google Scholar
• Laine R. O., Esser A. F. Identification of the discontinuous epitope in human complement protein C9 recognized by anti-melittin antibodies. J. Immunol. 1989; 143: 553
   PubMedGoogle Scholar
• Schultz D. R., Arnold P. I. Venom of the ant Pseudomyrmex sp.: further characterization of two factors that affect human complement proteins. J. Immunol. 1977; 119: 1690
   PubMedGoogle Scholar
• Schultz D. R., Arnold P. I., Wu M. C., Lo T. M., Volanakis J. E., Loos M. Isolation and partial characterization of a polysaccharide in ant venom (Pseudomyrmex sp.) that activates the classical complement pathway. Molecular Immunol. 1979; 16: 253
   PubMedGoogle Scholar
• De Carolis C., Perricone R., De Sanctis G., Fonatana L. Complement activation by Hymenoptera venom allergenic extracts. J. Allergy Clin. Immunol. 1982; 70: 219
   PubMedGoogle Scholar
• Russel F. E. Injuries by venomous animals in the United States. JAMA 1961; 177: 903
   PubMedGoogle Scholar
• Anderson P. C. Necrotizing spider bites. Amn. Fam. Physician 1982; 26: 198
   PubMed Web of Science ®Google Scholar
• Hufford D. C. The brown recluse spider and necrotic arachnidism. J. Arkansas Med. Soc. 1977; 74: 126
   PubMedGoogle Scholar
• Wasserman G. S., Anderson P. C. Loxoscelism and necrotic arachnidism. J. Toxicol.- Clin. Toxicol. 1983–84; 21: 451
   PubMed Web of Science ®Google Scholar
• Wasserman G. S., Siegel C. J. Loxoscelism (Brown recluse Spider Bites): A review of Literature Vet. Human. Toxicol. 1977; 19: 256
   Google Scholar
• Barreto O. C.O., Cardoso J. L.C., De Cillo D. Viscerocutaneous form of loxoscelism and erythrocyte glucose-6 phosphate deficiency. Rev. Inst. Med. Trop. São Paulo 1985; 27: 264
   PubMedGoogle Scholar
• Pizzi T., Zacarias J., Schenone H. Estudio histopatologico experimental en el envenenamiento por Loxosceles laeta. Biologica (Santiago) 1957; 23: 33
   Google Scholar
• Atkins J. A., Wingo C. W., Sodeman W. A., Wynn J. E. Necrotic Arachnidism. Am. J. Trop. Med. Hyg. 1958; 7: 165
   PubMed Web of Science ®Google Scholar
• Kniker W. T., Morgan P. N., Flanigan W. J., Reagan P. W., Dillha C. J. An inhibitor of complement in the venom of the brown recluse spider. Loxosceles reclusa. Proc. Soc. Exp. Biol. Med. 1969; 131: 1432
   PubMed Web of Science ®Google Scholar
• Barbaro K. C., Cardoso J. L.C., Eickstedt V. R.D.V., Mota I. Dermonecrotic and lethal components of Loxosceles gaucho Spider venom. Toxicon 1992; 30: 331
   PubMed Web of Science ®Google Scholar
• Smith C. W., Micks D. W. The role of polymorphonuclear leukocytes in the lesion caused by the venom of the brown spider, Loxosceles reclusa. Lab. Investigation 1970; 22: 90
   PubMed Web of Science ®Google Scholar
• Kniker W. T., Morgan P. N. An activator in spider venom of the fifth component of complement (C'5). Fed. Proc. 1967; 26: 362
   Google Scholar
• Morgan B. B., Morgan P. N., Bowling R. E. Lysis of human erythrocytes by venom from the brown recluse spider, Loxosceles reclusa. Toxicon 1978; 16: 85
   PubMed Web of Science ®Google Scholar
• Futrell J. M., Morgan P. N. Identification and neutralization of biological activities associated with venom from the brown recluse spider, Loxosceles reclusa. Am. J. Trop. Med. Hyg. 1977; 26: 1206
   PubMedGoogle Scholar
• Futrell J. M., Morgan P. N., Su S. P. C., Roth S. I. Inhibition of human complement components by Loxosceles reclusa venom. Int. Arch. Allergy Appl. Immunol. 1978; 57: 275
   PubMedGoogle Scholar
• Gebel H. M., Finke J. H., Elgert K. D., Campbell B. J., Barret J. T. Inactivation of complement by Loxosceles reclusa spider venom. American J. Trop. Med. Hyg. 1979; 28: 756
   PubMedGoogle Scholar
• Kurpiewski G., Campbell B. J., Forrester L. J., Barret J. T. Alternate complement pathway activation by recluse spider venom. Int. J. Tissue React. 1981; 3: 39
   PubMedGoogle Scholar
• Rees R. S., O'Leary J. P., King L. E. The pathogenesis of systemic loxoscelism following brown recluse spider bites. J. Surg. Res. 1983; 35: 1
   PubMed Web of Science ®Google Scholar
• Magnoli F. C., Freitas M. C.W., Campos A. C.M.R., Eickstedt V. R.D., Petricevich V. L., Sucupira M., Dias da Silva W. Factors associated with complement activation in Spider venoms, (manuscript in preparation)
   Google Scholar
• Changeux J. P., Kasai M., Lee C. Y. Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc. Natl. Acad. Sci., USA 1970; 67: 1241
   PubMed Web of Science ®Google Scholar
• Neubig R. R., Cohen J. B. Permeability control by cholinergic receptors in Torpedo postsynaptic membranes: Agonist dose-response relations measured at second and millisecond times. Biochemistry 1980; 19: 2770
   PubMedGoogle Scholar
• Chang C. C., Dong Lee J. The presynaptic neuromuscular blocking action of Taipoxin: A comparison with B-bungarotoxin and crotoxin. Toxicon 1977; 15: 571
   PubMed Web of Science ®Google Scholar
• Vital Brazil O. Venenos oftdicos neurotóxicos. Rev. Ass. Med. Brasil 1980; 26: 212
   Google Scholar
• Dias da Silva W., Lepow I. H. Complement as mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of humam complement. J. Exp. Med. 1967; 125: 921
   PubMedGoogle Scholar
• Dias da Silva W., Eisele J., Lepow I. H. Complement as a mediator of inflammation: III. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C3. J. Exp. Med. 1967; 126: 1027
   PubMed Web of Science ®Google Scholar
• Mandelbaum F. R., Assakura M. T. Antigenic relationship of haemorrhagic factors and proteases isolated from the venoms of three species of Bothrops snakes. Toxicon 1988; 26: 379
   PubMed Web of Science ®Google Scholar
• Rocha de Silva M., Beraldo W. T., Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and trypsin. Am. J. Physiol. 1950; 156: 261
   Google Scholar
• Stocker K., Barlow G. H. The coagulant enzyme from Bothrops atrox venom (batroxobin). Methods Enzymol. 1976; 45: 214
   PubMedGoogle Scholar
• Stocker K., Fisher H., Meier J. Thrombin-like snake venom proteinases. Toxicon 1982; 20: 265
   PubMed Web of Science ®Google Scholar
• Ewing C. B. The action of rattlesnake venom upon the bactericidal power of the blood serum. Lancet 1894; 1: 1236
   Google Scholar
• Stephens J. W.W., Myers W. The action of cobra poison on the blood: a contribution to the study of passive immunity. J. Path. Bacteriol. 1898; 5: 279
   Google Scholar
• Flexner S., Noguchi H. Snake venom in relation to haemolysis, bacteriolysis and toxicity. J. Exp. Med. 1903; 6: 227
   Google Scholar
• Sachs H., Omorokow L. Uber die wirkung des cobragiftes anf die komplemente. II. Mitteilung. Z. Immun. Forsch. 1911; 11: 710
   Google Scholar
• Ritz H. Über die wirkung des cobragiftes auf die komplemente. III. Mitteilung zugleich ein beitrag zur kenntnis der hamolytischen komplemente. Z. Immun-Forsch. 1912; 13: 62
   Google Scholar
• Coca A. F. A study of the anticomplementary action of yeast, of certain bacteria and of cobra-venom. Z. Immun. Forsch. 1914; 21: 604
   Google Scholar
• Müller-Eberhard H. J., Fjellström K. E. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J. Immunol. 1971; 107: 1666
   PubMedGoogle Scholar
• Götze O., Müller-Eberhard H. J. The C3 activator system: an alternate pathway of complement activation. J. Exp. Med. 1971; 134: 90s
   PubMed Web of Science ®Google Scholar
• Alper C. A., Rosen F. S. Genetic aspects of the complement system. Advances in Immunology, H. G. Kunkel, F. J. Dixon. Academic Press, New York 1971; vol. XIV: 251–290
   Google Scholar
• Lachmann P. J., Halbwacks L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin. Exp. Immunol. 1975; 21: 109
   PubMed Web of Science ®Google Scholar
• Vogel C. W., Müller-Eberhard H. J. The cobra venom factor-dependent C3 convertase of human complement A Kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 1982; 257: 8292
   PubMed Web of Science ®Google Scholar
• Pickering R. J., Wolfson M. R., Good R. A., Gewurz H. Passive hemolysis by serum and cobra venom factor: A new mechanism inducing membrane damage by complement. Proc, Natl. Acd. Sci. (USA) 1969; 62: 521
   PubMedGoogle Scholar
• Eggertsen G., Lind P., Sjöquist J. Molecular characterization of the complement activating protein in the venom of the indian cobra (Naja n siamensis). Molecular Immunology 1981; 18: 125
   PubMed Web of Science ®Google Scholar
• Tambourgi D. V., dos Santos M. C., Furtado M. F.D., Freitas M. C.W., Dias da Silva W., Kipnis T. L. Pro-inflammatory activities in elapid snake venoms. Br. J. Pharmacol. 1994; 112: 723
   PubMed Web of Science ®Google Scholar
• Lachmann P. J., Nicol P. Reaction mechanism of the alternative pathway of complement fixation. Lancet 1973; I: 465
   Google Scholar
• Alper C. A., Colten H. R., Gear J. S.S., Rabson A. R., Rosen F. S. Homozygous human C3 deficiency. The role of C3 in antibody production, C1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J. Clin. Investigation 1976; 57: 222
   PubMed Web of Science ®Google Scholar
• Alper C. A., Balavitch D. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science 1976; 191: 1275
   PubMedGoogle Scholar
• Grier A. H., Shultz M., Vogel C. W. Cobra venom factor and human C3 share carbohydrate antigenic determinants. J. Immunol. 1987; 139: 1245
   PubMedGoogle Scholar
• O'Keefe M. C., Caporale L. H., Vogel C. W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol Chem. 1988; 263: 12690
   PubMedGoogle Scholar
• Dias da Silva W., Calich V. L.G., Kipnis T. L., Rosen F. S., Alper C. A. Complement in the serum and venom of Brazilian Snakes (CROTALIDAE). Acta Pathol. Microb. Scand. 1985; 92(Suppl)97
   Google Scholar
• Minta J. O., Man D. P., Wasi S., Painter R. H. Interaction of Crotalus atrox venom with serum complement: Kinetic analysis. Immunochemistry 1977; 14: 513
   PubMedGoogle Scholar
• Man D. P., Minta J. O. Purification, characterization and analysis of the mechanism of action of four anti-complementary factors in Crotalus atrox venom. Immunochemistry 1977; 14: 521
   PubMedGoogle Scholar
• Rael E. D., Jones L. P. Isolation of an anticomplement factor from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus). Toxicon 1983; 21: 57
   PubMedGoogle Scholar
• Eggertsen G., Fohlman J., Sjöquist J. In vitro studies on complement inactivation by snake venoms. Toxicon 1980; 18: 87
   PubMedGoogle Scholar
• Shin H. S., Gewurz H., Snyderman R. Reaction of a cobra venom factor with guinea pig complement and generation of an activity chemotactic for polymorphonuclear leukocytes. Proc. Soc. Exp. Biol. Med. 1969; 131: 203
   PubMed Web of Science ®Google Scholar